Optimizing White Space Engagement: Best Practices and Operational Strategies
In the pharmaceutical industry, engaging healthcare practitioners (HCPs) in white space territories—areas where traditional sales forces have limited reach—is a critical challenge. With a smaller sales force, brand leaders must develop effective white space engagement campaigns and sample programs to ensure comprehensive coverage.
Veeva/Salesforce CRM Split: Risks and Mitigation Strategy
In December 2022, Veeva Systems made the significant announcement that it would not renew its partnership with Salesforce upon its expiration in September 2025.
Enhancing Patient Care with Innovative Medication Sample Solutions
In today’s healthcare landscape, ensuring patients have access to necessary medications is crucial for preventing hospital visits and improving overall health outcomes.
How Will You Transition Your CRM During the Veeva – Salesforce CRM Separation?
In December 2022, Veeva Systems made the significant announcement that it would not renew its partnership with Salesforce upon its expiration in September 2025.
Direct-to-Practitioner (DTP) vs. Hand-Carry: Choosing the Right Pharmaceutical Sampling Strategy
Choosing the right distribution method impacts compliance, cost, scalability, and HCP engagement. In this post, we’ll explore the differences between DTP and hand-carry programs, the benefits and challenges of each, and how QPharma can help you determine and implement the optimal strategy.
What type of Direct-to-Practitioner (DTP) sampling program is right for you?
In the dynamic and continually evolving field of pharmaceutical sampling, companies are persistently exploring innovative and cost-effective methods to engage healthcare practitioners via omnichannel marketing.
How to Choose a Life Sciences Compliant Learning Management System (LMS) Vendor
This blog post will guide you through the critical factors to consider when choosing both a life science-compliant LMS and the right industry vendor.
The Critical Role of Practitioner Validation in PDMA Compliance
The Prescription Drug Marketing Act (PDMA) regulates the distribution and marketing of prescription drugs, particularly the handling of drug samples
Case for remote detailing and tele-sampling for cost-effective HCP engagement
In recent years, the life-sciences industry has undergone a significant shift in how it engages with healthcare professionals (HCPs).
Sample Compliance – A Case for Third Party Inspections and Inventories
The Prescription Drug Marketing Act “PDMA” (21 CFR part 203, subpart D) mandates that pharmaceutical drug manufacturers and authorized distributors of record (ADRs) keep detailed information about the distribution of prescription drug samples.
